FDA Letter API

Samba Premium Tobacco, Inc.

Letter data

Company
Samba Premium Tobacco, Inc.
Recipient
Sasha Josef Friwat and Samar Itani | Samba Premium Tobacco, Inc. | 934 S. Andreasen Dr. | Ste F | Escondido | , | CA | 92029 | United States | support@sambatobacco.com | sambatobacco@gmail.com
Issue date
2020-11-02
Posted date
Not available
FDA office
Division of Promotion, Advertising, and Labeling
Subject
Not available
Product
Not available
CMS ID
598724
Reference number
RW1901232
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Samba Premium Tobacco, Inc. MARCS-CMS 598724 — November 02, 2020 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UPS and Electronic Mail Reference #: RW1901232 Recipient: Recipient Name Sasha Josef Friwat and Samar Itani Samba Premium Tobacco, Inc. 934 S. Andreasen Dr. Ste F Escondido , CA 92029 United States support@sambatobacco.com sambatobacco@gmail.com Issuing Office: Division of Promotion, Advertising, and Labeling United States Dear Sasha Josef Friwat and Samar Itani: The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions in response to our Warning Letter dated December 20, 2019. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://www.sambatobacco.com. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future. Sincerely, /S/ David Rice Branch Chief Division of Promotion, Advertising, and Labeling Office of Compliance and Enforcement Center for Tobacco Products Content current as of: 11/25/2020